Clinical trials for Anal cancer

87 currently recruiting clinical trials
Phase 2 Breast cancer Lung cancer Prostate cancer Colon cancer Rectal cancer Anal cancer Kidney cancer Pancreas cancer Liver and bile duct cancer Stomach and esophageal cancer #NCT05503797 #2024-513578-23-00
Neuroendocrine tumor Locally Advanced Metastatic BRAF 1 2 3 or more
HRAS KRAS G12C KRAS non G12C NRAS Systemic Treatment-Naive
Hôpital Nord de Marseille (Marseille Cedex 20), Institut Bergonié (Bordeaux), Gustave Roussy (Villejuif), Hôpital Pitié Salpêtrière - AP-HP (Paris), IUCT Oncopôle (Toulouse) (and 2 more...)
Fore Biotherapeutics
Phase 2 Breast cancer Lung cancer Prostate cancer Colon cancer Rectal cancer Anal cancer Kidney cancer Pancreas cancer Liver and bile duct cancer Bladder / Urinary Tract / Urethral cancer Stomach and esophageal cancer Endometrial cancer Ovarian / Fallopian tubes / Peritoneum cancer #NCT05503797 #2024-513578-23-00
Locally Advanced Metastatic BRAF 1 2 3 or more
KRAS G12C KRAS non G12C NRAS HRAS Systemic Treatment-Naive
Institut Bergonié (Bordeaux), Hôpital Pitié Salpêtrière - AP-HP (Paris), Gustave Roussy (Villejuif), Hôpital Nord de Marseille (Marseille Cedex 20), Institut de Cancérologie de l'Ouest - Site d'Angers (Angers ) (and 2 more...)
Fore Biotherapeutics
Phase 2 Colon cancer Rectal cancer Anal cancer #NCT04268121 #2024-515603-19-01
Neuroendocrine tumor Localized None Systemic Treatment-Naive
Centre Hospitalier Universitaire de Toulouse (Toulouse), Gustave Roussy (Villejuif), Hôpital Edouard Herriot - Hospices Civils de Lyon (Lyon), Centre hospitalier universitaire François Mitterrand (Dijon), Hôpital Saint Antoine AP-HP (Paris) (and 5 more...)
GERCOR - Groupe Coopératif Multidisciplinaire d'Oncologie
Phase 2 Breast cancer Lung cancer Prostate cancer Colon cancer Rectal cancer Anal cancer Kidney cancer Pancreas cancer Liver and bile duct cancer Bladder / Urinary Tract / Urethral cancer Stomach and esophageal cancer Endometrial cancer Ovarian / Fallopian tubes / Peritoneum cancer #NCT05503797 #2024-513578-23-00
Locally Advanced Metastatic BRAF 1 2 3 or more
KRAS G12C KRAS non G12C NRAS HRAS Systemic Treatment-Naive
Institut Bergonié (Bordeaux), Hôpital Pitié Salpêtrière - AP-HP (Paris), Hôpital Nord de Marseille (Marseille Cedex 20), Institut de Cancérologie de l'Ouest - Site d'Angers (Angers ), Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest) (and 2 more...)
Fore Biotherapeutics
Phase 2 Colon cancer Rectal cancer Anal cancer #NCT04954820
Neuroendocrine tumor 1
Systemic Treatment-Naive Systemic Treatment-Naive
Institut de Cancérologie de l'Ouest - Site d'Angers (Angers ), Centre Jean Perrin (Clermont Ferrand ), Institut du cancer de Montpellier (Montpellier), Institut Bergonié (Bordeaux), Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest) (and 21 more...)
Institut du Cancer de Montpellier - Val d'Aurelle
Phase 2 Colon cancer Rectal cancer Anal cancer Pancreas cancer Liver and bile duct cancer Stomach and esophageal cancer #NCT06475352
Locally Advanced Metastatic None Systemic Treatment-Naive
Centre Hospitalier Universitaire de Clermont Ferrand (Clermont-Ferrand), Centre Hospitalier Régional d'Orléans Hôpital de La Source (Orléans), Centre Hospitalier Universitaire de Besançon (Besançon), Hôpital Privé Drome Ardèche - Clinique Générale - Ramsay Santé (Valence), Centre Hospitalier de la Côte Basque (Bayonne) (and 30 more...)
UNICANCER
Phase 1 / Phase 2 Breast cancer Lung cancer Prostate cancer Colon cancer Rectal cancer Anal cancer Kidney cancer Pancreas cancer Liver and bile duct cancer Bladder / Urinary Tract / Urethral cancer Stomach and esophageal cancer Endometrial cancer Ovarian / Fallopian tubes / Peritoneum cancer #NCT04939610 #2023-508995-12-01
Phase 1: Escalade de dose
Locally Advanced Metastatic Metastatic Castration-resistant 1 2 3 or more
Systemic Treatment-Naive
CHRU de Nancy - Hôpitaux de Brabois (Vandœuvre-lès-Nancy), Institut Bergonié (Bordeaux), Centre Jean Perrin (Clermont Ferrand ), Institut du cancer de Montpellier (Montpellier)
Novartis
Phase 1 / Phase 2 Breast cancer Lung cancer Prostate cancer Colon cancer Rectal cancer Anal cancer Kidney cancer Pancreas cancer Liver and bile duct cancer Bladder / Urinary Tract / Urethral cancer Stomach and esophageal cancer Endometrial cancer Ovarian / Fallopian tubes / Peritoneum cancer #NCT06818643 #2024-516817-19-00
Locally Advanced Metastatic 1 2 3 or more
Systemic Treatment-Naive
Centre Eugene Marquis (Rennes), Centre Oscar Lambret (Lille), Gustave Roussy (Villejuif), Institut Paoli-Calmettes (Marseille)
Merck Sharp & Dohme LLC
Phase 1 / Phase 2 Breast cancer Lung cancer Prostate cancer Colon cancer Rectal cancer Anal cancer Kidney cancer Pancreas cancer Liver and bile duct cancer Bladder / Urinary Tract / Urethral cancer Stomach and esophageal cancer Endometrial cancer Ovarian / Fallopian tubes / Peritoneum cancer #NCT06833008 #2024-519184-18-00
Metastatic BRAF KRAS G12C KRAS non G12C NRAS HRAS KRAS G12D
Systemic Treatment-Naive
Gustave Roussy (Villejuif), Hôpital Saint Louis AP-HP (Paris)
Epizyme, Inc. (Ipsen)
Phase 1 / Phase 2 Breast cancer Lung cancer Prostate cancer Colon cancer Rectal cancer Anal cancer Kidney cancer Pancreas cancer Liver and bile duct cancer Bladder / Urinary Tract / Urethral cancer Stomach and esophageal cancer Endometrial cancer Ovarian / Fallopian tubes / Peritoneum cancer #NCT06898450
Parties A and B (Patients non sélectionnés)
Locally Advanced Metastatic Metastatic Castration-resistant 1 2 3 or more
Systemic Treatment-Naive
Centre Hospitalier Universitaire de Poitiers - Site de la Milétrie (Poitiers), Hôpital Saint Antoine AP-HP (Paris)
Nimbus Wadjet, Inc.